2013 Archive

May 2013

BREAKING RESEARCH NEWS: Stem-Cell Generated Thymus Tissue to Catalyze New Treatments for Transplantation, Type 1 Diabetes and Other Autoimmune Diseases -
UCSF Diabetes Center researchers Matthias Hebrok, PhD, and Mark Anderson, MD, PhD, have created in their labs the first functioning human thymus tissue derived from embryonic stem cells – a huge step forward in producing new cell therapies to treat numerous diseases including type 1 diabetes.

April 2013

Interested in Type 1 Diabetes research? We are interested in you! -
UCSF Diabetes Center offers intervention clinical trials for people with type 1 diabetes, as well as prevention studies for relatives of type 1 diabetes patients.

January 2013

Study Challenges Chromium Therapy for the Treatment of Insulin Resistance -
UCSF endocrinologist Umesh Masharani and his colleagues have dispelled a commonly held belief that chromium supplements improve insulin sensitivity and help prevent and treat diabetes.
Stopping the Inflammatory Response in Type 2 Diabetes -
Diabetes Center investigator Suneil Koliwad, MD, PhD, is exploring how nutritional factors may stimulate tissue inflammation and increase the risk for developing type 2 diabetes.
Coaxing Human Stem Cells into Insulin-Producing Beta Cells -
Center Director Matthias Hebrok, PhD, and his lab colleagues have optimized existing culture conditions to increase the number of pancreas progenitor cells and insulin-producing cells from human stem cells.
Holiday Greetings from our Center Director -
 As another year concludes, I continue to feel enormous pride for all that we have accomplished.

February 2013

Tour de Cure with TEAM UCSF -
 Join TEAM UCSF in participating in the American Diabetes Association (ADA) Tour de Cure scheduled for Sunday, May 5th in the Napa Valley.
 
//